Richard Esmond Beatson

7PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 13, 2026
Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.

|Aug 05, 2024
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

Jinhai Deng, Teng Pan, Dan Wang

|Oct 04, 2023
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.

Jinhai Deng, Teng Pan, Zaoqu Liu

|Jul 27, 2022
CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor.

Daniela Yordanova Achkova, Richard Esmond Beatson, John Maher

|Nov 27, 2021
Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease.

Sabrina Ceeraz, Charlotte R Thompson, Richard Beatson

|Aug 07, 2021
Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.

Ester Pfeifer, Joy M Burchell, Francesco Dazzi

Pageof 2

Frequent Collaborators

2 joint publications

Zaoqu Liu

2 joint publications

Tony Ng

1 joint publications

Rosalind Graham

1 joint publications

Domenico Cozzetto